{"id":"NCT00539240","sponsor":"US Department of Veterans Affairs","briefTitle":"Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI","officialTitle":"Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-04","primaryCompletion":"2010-04","completion":"2011-11","firstPosted":"2007-10-04","resultsPosted":"2014-08-18","lastUpdate":"2014-08-18"},"enrollment":236,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Gastroesophageal Reflux Disease"],"interventions":[{"type":"DRUG","name":"Rabeprazole 20mg, placebo dinner and bedtime","otherNames":["AcipHex"]},{"type":"DRUG","name":"Rabeprazole 20 mg two times, Placebo at bedtime","otherNames":["Aciphex"]},{"type":"DRUG","name":"Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant","otherNames":["Nortriptyline and Aciphex"]}],"arms":[{"label":"Rabeprazole morning/evening placebo bedtime","type":"PLACEBO_COMPARATOR"},{"label":"Rabeprazole breakfast, placebo dinner and bedtime","type":"PLACEBO_COMPARATOR"},{"label":"Rabeprazole breakfast, placebo dinner, nortriptyline bedtime","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this project is to compare the efficacy (how successful) 1) standard-dose proton pump inhibitor (PPI) (rabeprazole 20 mg once daily) (a medication that completely blocks the stomach from producing acid) plus low dose tricyclic antidepressant (nortriptyline 50mg) (TCA); 2) double-dose PPI (rabeprazole 20 mg twice a day); to 3) standard-dose PPI (rabeprazole 20mg once daily) and placebo (an inactive substance, like a sugar pill) to determine the relative symptom resolution and health-related quality of life in gastroesophageal reflux disease (a disease characterized by a burning sensation (heartburn) behind the breast bone caused by a backflow of stomach contents into the esophagus) (GERD) patients who fail standard-dose PPI and you will be randomly assigned (similar to flipping a coin) to one of the three groups.","primaryOutcome":{"measure":"Daytime Heartburn, Number of Days in Week Symptoms Intensity Score < 3 (Better)","timeFrame":"Symptom control after 6 weeks of treatment","effectByArm":[{"arm":"Arm 1","deltaMin":6.6,"sd":0.9},{"arm":"Arm 2","deltaMin":5.9,"sd":2.2},{"arm":"Arm 3","deltaMin":6.1,"sd":1.8}],"pValues":[{"comp":"OG000 vs OG001","p":"0.04"},{"comp":"OG001 vs OG002","p":"0.50"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":11},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":59},"commonTop":["Somnolence","Constipation","Dry mouth","Blurred vision","Flu like symptoms"]}}